Kristy Miskimen

996 citations
31 papers · 634 indexed · h-index 13
Topics
Ubiquitin and proteasome pathways (4 papers)HER2/EGFR in Cancer Research (4 papers)Chronic Myeloid Leukemia Treatments (4 papers)

In The Last Decade

Kristy Miskimen

29 papers receiving 630 citations

Peers

Kristy Miskimen
Comparison fields: 5 of 67
  • Molecular Biology 392
  • Oncology 262
  • Cancer Research 208
  • Pulmonary and Respiratory Medicine 114
  • Immunology 83
Replace М. В. Немцова with:
М. В. Немцова Russia
Thai H. Tran United States
James R. Hernandez United States
Zaletaev Dv Russia
Sarah Short United States
Shuet Theng Lee Singapore
Ginés Luengo‐Gil Spain
Qingqing Ding United States
Xiangshu Jin China
Sangok Kim South Korea
Kristy Miskimen relative to М. В. Немцова Russia М. В. Немцова's profile →
Citations per field
00.5×6.5×
М. В. Немцова · 1×
Citations per year

Countries citing papers authored by Kristy Miskimen

Since Specialization
Citations

This map shows the geographic impact of Kristy Miskimen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristy Miskimen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristy Miskimen more than expected).

Fields of papers citing papers by Kristy Miskimen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristy Miskimen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristy Miskimen. The network helps show where Kristy Miskimen may publish in the future.

Co-authorship network of co-authors of Kristy Miskimen

This figure shows the co-authorship network connecting the top 25 collaborators of Kristy Miskimen. A scholar is included among the top collaborators of Kristy Miskimen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristy Miskimen. Kristy Miskimen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 5
3 1
4 1
5 0
6 0
7 28
8 27
9
Somatic T-cell Receptor Diversity in a Chronic Kidney Disease PatientPopulation Linked to Electronic Health Records.
5
10 75
11 16
12 14
13 86
14 2
15 90
16 32
17 46
18 78
19 24
20 11

About Kristy Miskimen

Kristy Miskimen is a scholar working on Genetics, Hematology and Transplantation, having authored 31 papers that have together received 634 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (4 papers), HER2/EGFR in Cancer Research (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). The work is most often cited by research in Cancer Research (208 citations), Oncology (262 citations) and Molecular Biology (392 citations). Kristy Miskimen has collaborated with scholars based in United States, Austria and China. Frequent co-authors include Mark W. Jackson, Rocky Cipriano, Benjamin L. Bryson, Courtney A. Bartel, Lyndsay N. Harris, Hannah Gilmore, Kevin D. Bunting, Ronald C. Bruntz, Sarah Scott and H. Alex Brown. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026